ACCESS Newswire

Aviwell Closes €11 Million Series A Investment Round to Scale AI‑Driven Microbiota Platform for Sustainable Animal Nutrition

23.1.2026 06:01:00 CET | ACCESS Newswire | Press Release

Share

TOULOUSE, FRANCE AND BOSTON, MA / ACCESS Newswire / January 23, 2026 / Aviwell SAS, a deep‑tech animal nutrition company headquartered in Toulouse, today announced the successful completion of a €11 million Series A investment round, welcoming three new investors: Blue Revolution Fund (BRF), Blast.Club, and SWEN Capital Partners. The financing will support Aviwell's next phase of growth as the company scales its AI‑driven microbiome discovery and development platform and advances native, nature‑based biological solutions for global agri‑food markets, initially focused on poultry and aquaculture.

Built on decades of research pioneered by Aviwell's co‑Founder, Prof. Remy BURCELIN, into how naturally occurring bacterial ecologies administered early in life can have a durable impact on animal growth, health, and resilience, Aviwell has developed Aneto™, an AI‑powered microbiome discovery platform.

Aneto™ identifies specific molecular mechanisms - modes of action - that enable the selection of native bacterial communities to create tailored bacterial ecologies designed to enhance animal performance, immunity, and robustness. This approach delivers a highly efficient discovery process, reducing research and development timelines and costs while accelerating time to market.

By combining advanced microbiota analysis with AI and machine‑learning‑driven discovery, Aviwell delivers measurable improvements in feed efficiency and immune function support while significantly lowering the cost and complexity of developing next‑generation animal nutrition solutions.

Aviwell will use the newly raised capital to advance its poultry and aquaculture microbial ecologies from discovery through validation and scale‑up. The company will also expand Aneto™ platform services, strengthen discovery and demonstration capabilities, and deepen commercial engagement with partners and customers.

"Aviwell sits at the intersection of two powerful market forces: rising global demand for animal protein, and the accelerating consumer shift toward natural, sustainable, antibiotic‑free production systems," explained Mouli RAMANI, the President and CEO of Aviwell. "With Aneto™, we can translate microbiome complexity into practical, scalable solutions-helping livestock and aquaculture producers improve productivity while reducing their environmental footprint. With the support of our new investors, Aviwell will accelerate development in poultry and aquaculture and expand our platform and product pipeline."

The financing round was led by Blue Revolution Fund (BRF), which invests globally in sustainable aquaculture, alternative seafood, and nutrition solutions. Georg BAUNACH, Managing Partner at BRF, stated: "We are deeply impressed by Aviwell's scientific depth and technological precision. Aneto™ represents a new generation of microbiome innovation-one that captures the inherent complexity of biological systems. We believe this approach can unlock the next wave of solutions for poultry, aquaculture and livestock in general by delivering meaningful improvements in performance, resilience and environmental footprint."

Blast Club also joins the round, reinforcing its commitment to innovative agri‑food technologies through equity crowdfunding. "We invested in Aviwell for one simple reason: they are revolutionizing the agri‑food industry. Aviwell uses AI and life sciences to naturally boost animal growth, without hormones or antibiotics, simply by working on the microbiota," shared Anthony BOURBON, founder of Blast.Club. "That's what we like: impact, innovation and a real long‑term vision. Feeding better, in a healthier, more sustainable way. Changing the rules of the game instead of playing by them."

The third new investor, SWEN Capital Partners, is a Paris‑based responsible investment firm active across private equity, infrastructure, private debt, and direct impact strategies. "Investing in the microbiome means investing in the future of health and a sustainable economy. For us, supporting Aviwell is about building a measurable, sustainable economic model - reducing chronic disease costs and creating responsible, long-term value," said Julien BOURRET, Investment Director at SWEN CP.

The three new investors join Aviwell's existing investors, including Elaia and MFS Investment Management, who also participated in the round.

With this Series A financing, Aviwell is positioned to accelerate the translation of cutting-edge microbiome science into scalable, nature-based solutions for animal nutrition. By advancing its AI-driven Aneto™ platform and expanding commercial collaborations, the company aims to support more resilient, efficient, and sustainable protein production systems worldwide.

Aviwell Press Kit

About Aviwell
Founded in France, Aviwell is a deep-tech animal nutrition company developing next-generation, microbiome-based solutions to improve animal health, performance, and robustness. Leveraging its proprietary Aneto™ AI-driven discovery platform, Aviwell designs native bacterial ecologies with defined modes of action to support productivity while reducing reliance on antibiotics. The company initially focuses on poultry and aquaculture, addressing key sustainability challenges in global agri-food systems. www.aviwell.fr

About BRF:

The Blue Revolution Fund (BRF) is a €92M global venture capital vehicle, managed by Hatch Blue, focused on scaling the aquaculture industry through sustainable innovation. Hatch Blue is a specialist asset manager and professional services firm that leverages three strategic pillars - Investment (Hatch Funds I/II and BRF), Consulting, and Programs - to catalyze growth across the global blue economy. Learn more at BRF Hatch Blue

About Blast.Club

Founded in 2023 by Anthony Bourbon and Samuel Guez, Blast is a private investment club that invested €125 million in 2025. With a team of over 60 employees, Blast focuses in particular on new technologies (Deeptech, AI, Biotech, Medtech, etc.) The investment club now brings together more than 14,000 engaged members, offering a strong and dynamic network for investors and entrepreneurs. More information at blast.club

About SWEN Capital Partners:

SWEN Capital Partners is a key player in sustainable investment across private equity, infrastructure, and mezzanine debt, with over €10 billion* in assets under management and advisory, and more than 120 employees. The management company is part of the Ofi Invest Group - whose main shareholders are entities of the Aéma Group (Macif, Abeille Assurances Holding, Aésio Mutuelle) - and SWEN Managers, a holding company owned by around 50 employees. From the outset, SWEN has placed sustainable finance at the core of its strategy, offering clients innovative and responsible investment solutions. In February 2024, SWEN CP became a Mission driven company, marking a decisive commitment to serving Nature. * Cumulative commitments as of September 1, 2025

Learn more at swen-cp.com

Media Contacts

Aviwell SAS
David GILBERT, VP Business Development
david@aviwell.fr

Blue Revolution Fund
Sol PARK, Principal
sol@hatch.blue

Blast.Club
Emilie BAUER, Head of Communication
eb@blast.club - 06 75 19 42 81

SWEN CP
Lola FORNARI
LFORNARI@swen-cp.fr

End of Release

SOURCE: Aviwell USA



View the original press release on ACCESS Newswire

Aviwell USA

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Formerra and Evonik Expand Distribution Partnership for Healthcare Grades2.2.2026 15:00:00 CET | Press Release

Agreement Expands Access to Evonik's CARE Brand Medical Grades in the U.S. and Canada ROMEOVILLE, ILLINOIS / ACCESS Newswire / February 2, 2026 / Formerra, a leader in performance materials distribution, today announced an expanded distribution agreement that brings Evonik's CARE brand healthcare grades into Formerra's medical portfolio. Covering the United States and Canada, the agreement creates new access points for high-performance polyamides used in essential healthcare applications. This expansion kicks off at MD&M West 2026 this week, and underscores both companies' commitment to supporting the healthcare market with high-performance materials, responsive service, and continuity of supply. It also builds on the companies' two-year partnership, which introduced Evonik's VESTAMID® and TROGAMID® families to Formerra's engineered materials lineup. With this expansion, Formerra will support Evonik healthcare grades designed for fluid handling, drug delivery, diagnostic systems, surgi

Hans Vestberg, Former Verizon Chairman and CEO, Joins Digipower X As Senior Advisor2.2.2026 13:30:00 CET | Press Release

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated May 15, 2025. MIAMI, FL / ACCESS Newswire / February 2, 2026 / Digi Power X Inc. ("Digipower X" or the "Company") (Nasdaq:DGXX)(TSXV:DGX), a vertically integrated AI infrastructure company focused on the deployment of Tier-3 modular data centers powered by owned and controlled energy assets, today announced that Hans Vestberg, former Chairman and Chief Executive Officer of Verizon Communications, has joined the Company as a senior advisor serving on its Advisory Board to support the Company's expansion strategy. Mr. Vestberg brings more than three decades of global leadership in mission-critical infrastructure, telecommunications networks, and large-scale capital deployment. He is widely recognized for leading Verizon's first commercial 5G deployment in 2018 and for advancing nationw

Formerra to Supply Foster Medical Compounds in Europe29.1.2026 15:00:00 CET | Press Release

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds. PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions. Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials. "Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key

Sadie Launches Cloudbeds Integration to Automate Guest Calls and Reservation Management with Voice AI28.1.2026 17:25:00 CET | Press Release

MONTRÉAL, QUEBEC / ACCESS Newswire / January 28, 2026 / Sadie, the voice AI agent for the hospitality industry, today announced a new integration with Cloudbeds, the hospitality industry's leading unified platform, enabling hotels to automate guest calls while increasing direct bookings and freeing staff to focus on on-property service. Through the integration, Cloudbeds-powered hotels can deploy Sadie as an intelligent voice agent that answers calls instantly, shares real-time rates and availability, and creates and manages reservations directly within the Cloudbeds platform. Designed as an always-on extension of the front desk, Sadie ensures guest calls are answered instantly, day or night. From sharing real-time rates and availability to creating and modifying reservations, handling service requests, and assisting with overnight room lockouts, Sadie delivers immediate, multilingual support for both guests and hotel teams. By handling high-volume and after-hours calls, Sadie reduces

Power to Hydrogen Appoints David Bow as Chief Strategy Officer to Scale International Expansion28.1.2026 15:00:00 CET | Press Release

Industry Veteran Brings 25+ Years Of Senior Leadership In Hydrogen And Industrial Decarbonization COLUMBUS, OH / ACCESS Newswire / January 28, 2026 / Power to Hydrogen (P2H2), a developer of industrial-scale anion exchange membrane (AEM) electrolyzers designed for low-cost green hydrogen production, today announced that industry veteran David Bow has joined the company as Chief Strategy Officer. Bow will lead P2H2's corporate and commercial strategy as the company expands its industrial deployments and scales its go-to-market efforts in North America and Europe. His scope includes strategic partnerships, market entry and segmentation, commercial growth priorities, and alignment of product roadmap and validation plans with customer and financing requirements. Bow brings more than 25 years of senior leadership experience across hydrogen and industrial energy, including executive roles spanning commercialization, strategy, and scaling. He previously led Plug Power's Electrolyzer Solutions

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye